Getting started on MIMRYLO™ (rusfertide)

""
Getting started on MIMRYLO

What to expect when starting MIMRYLO

""

Starting MIMRYLO

  • MIMRYLO is self-administered as an injection just under the skin (subcutaneous injection)
  • Patients start treatment with a 19 mg dose taken once a week
  • Please review the Instructions for Use before you prepare and self-administer MIMRYLO, and each time you get a refill as there may be new information
""

Adjusting your MIMRYLO dose

Your healthcare provider will determine the dose that best meets your treatment needs. Dose adjustments may be made based on:

  • your hematocrit (HCT) levels
  • how you respond to MIMRYLO
  • any side effects

Blood tests (eg, complete blood count) will be checked regularly, especially during dose adjustments. Some MIMRYLO doses may require more than one injection on the same day or spaced throughout the week, depending on the amount prescribed.

""

Maintaining your dose

Once your HCT is under control, you will continue taking your prescribed dose once weekly, or as directed by your healthcare provider.

Infographic showing MIMRYLO injection sites: stomach (abdomen), at least 2 inches from navel (belly button); front of thigh; and outer area of upper arm (caregiver use only)

Administering MIMRYLO

Your healthcare provider will train you on how to administer MIMRYLO. 

MIMRYLO can be injected into the: 

  • Abdomen
  • Thigh
  • Upper arm (caregiver use only)

What to expect when preparing and injecting MIMRYLO

Infographic showing 5 steps for preparing and injecting MIMRYLO: 1. Prepare, 2. Mix, 3. Draw syringe, 4. Inject, 5. Dispose

Confidently administer at-home injections using your Welcome Kit

MIMRYLO™ Welcome Kit

Welcome Kit

Designed to help you get started on treatment, the MIMRYLO Welcome Kit includes helpful resources and information such as preparation and injection training, printed dosing guidance, Important Safety Information, and contact information for support services.

Didn't receive a kit? Enroll here
MIMRYLO PATIENT SUPPORT

MIMRYLO Patient Support is Here2Assist® as you get started on treatment

Support for people taking MIMRYLO

Starting a new treatment can be overwhelming—navigating insurance, administration, and questions. When you start MIMRYLO, you can enroll in MIMRYLO Patient Support, which offers personalized support to help you every step of the way. We also have additional services like nursing support and Welcome Kits to help support you.

Explore MIMRYLO Patient Support
Nursing support

Do you have questions on how to use MIMRYLO? Do you need help with your injections? Over the course of your injection education training session, your Nurse Navigators can help you learn more about the self-administration process.

Contact Nurse Support Services

*By enrolling in the MIMRYLO Patient Support Co-Pay Assistance Program (the “Program”), you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions:

You must be at least 18 years old, a resident of the United States or a US Territory, and have commercial (private) prescription insurance that does not cover the entire cost of the Takeda Oncology medication. The Program is not valid for patients whose prescription claims for the Takeda Oncology medication are eligible to be reimbursed, in whole or in part, by any state or federal healthcare program, including, but not limited to, Medicare, Medicaid, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, or any state or territory pharmaceutical assistance program. Patients who become eligible for or start using government insurance for their Takeda Oncology medications will no longer be eligible for the Program. The Program is not valid if the entire cost of your prescription is reimbursable by a private insurance plan or other private health or pharmacy benefit programs. You are responsible for reporting receipt of Program assistance to any insurer, health plan, or other third party who pays for or reimburses any part of the medication cost, as may be required.

You agree that you will not submit the cost of any portion of the product dispensed pursuant to this Program to a federal or state healthcare program (including, but not limited to, Medicare, Medicaid, TRICARE, VA, DoD, etc.), for purposes of counting it toward your out-of-pocket expenses, and to notify Takeda Oncology Here2Assist® if you become eligible for a federal or state healthcare program that covers your Takeda Oncology medication. This Program is not conditioned on any past, present or future purchase of any Takeda product, including refills. This Program is valid for up to 12 months, and your co-pay card may be renewed every 12 months, subject to continued eligibility at the beginning of each calendar year. This offer is not valid with any other program, discount, or offer involving your prescribed Takeda Oncology medication. This offer may be rescinded, revoked, or amended without notice. This offer is void where prohibited by law, taxed, or restricted. Limit one offer per purchase. No income requirements or membership fees. This Program is not health insurance. Cash value of 1/100 of 1¢. For questions about this offer, please contact the Takeda Oncology Co-Pay Assistance Program, a patient support service of Takeda Oncology Here2Assist, at 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET.

All individuals in images are actor portrayals.

IMPORTANT SAFETY INFORMATION

Expand